These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6747625)

  • 1. Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex.
    Kadan MJ; Krohn AM; Evans MJ; Waltz RL; Hartig PR
    J Neurochem; 1984 Sep; 43(3):601-6. PubMed ID: 6747625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N1-methyl-2-125I-lysergic acid diethylamide, a preferred ligand for in vitro and in vivo characterization of serotonin receptors.
    Hoffman BJ; Scheffel U; Lever JR; Karpa MD; Hartig PR
    J Neurochem; 1987 Jan; 48(1):115-24. PubMed ID: 3794694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain.
    Hartig PR; Scheffel U; Frost JJ; Wagner HN
    Life Sci; 1985 Aug; 37(7):657-64. PubMed ID: 3160905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic localization and characterization of [125I]lysergic acid diethylamide binding to serotonin receptors in Aplysia.
    Kadan MJ; Hartig PR
    Neuroscience; 1988 Mar; 24(3):1089-102. PubMed ID: 3380298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic and adrenergic regulation of skeletal muscle metabolism in the rat. II. The use of [125I]iodolysergic acid diethylamide and [125I]iodopindolol as probes of sarcolemmal receptor function and specificity.
    Moretti-Rojas I; Ezrailson EG; Birnbaumer L; Entman ML; Garber AJ
    J Biol Chem; 1983 Oct; 258(20):12499-508. PubMed ID: 6313663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
    McKenna DJ; Peroutka SJ
    J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and characterization by quantitative autoradiography of [125I]LSD binding sites in rat brain.
    Nakada MT; Wieczorek CM; Rainbow TC
    Neurosci Lett; 1984 Aug; 49(1-2):13-8. PubMed ID: 6493586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors.
    Engel G; Müller-Schweinitzer E; Palacios JM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):328-36. PubMed ID: 6728042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 125I-LSD: a high sensitivity ligand for serotonin receptors.
    Hartig PR; Kadan MJ; Evans MJ; Krohn AM
    Eur J Pharmacol; 1983 May; 89(3-4):321-2. PubMed ID: 6873167
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.
    Bennett JP; snyder SH
    Brain Res; 1975 Sep; 94(3):523-44. PubMed ID: 239784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.
    Elliott JM; Kent A
    J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex.
    Cummins JT; von Euler G; Fuxe K; Ogren SO; Agnati LF
    Neurosci Lett; 1987 Mar; 75(2):152-6. PubMed ID: 3574772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.
    Scheffel U; Lever JR; Stathis M; Ricaurte GA
    Neuropharmacology; 1992 Sep; 31(9):881-93. PubMed ID: 1359444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
    Ivins KJ; Molinoff PB
    Mol Pharmacol; 1990 May; 37(5):622-30. PubMed ID: 2160057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells.
    Yagaloff KA; Hartig PR
    J Neurosci; 1985 Dec; 5(12):3178-83. PubMed ID: 4078623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodinated D-(+)-N1-ethyl-2-iodolysergic acid diethylamide: a ligand for in vitro and in vivo studies of serotonin receptors.
    Lever JR; Scheffel UA; Musachio JL; Stathis M; Wagner HN
    Life Sci; 1991; 48(15):PL73-8. PubMed ID: 2011045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic comparison of [125I]LSD-labeled 5-HT2A receptor distribution in rat and guinea pig brain.
    Watts SW; Gackenheimer SL; Gehlert DR; Cohen ML
    Neurochem Int; 1994 Jun; 24(6):565-74. PubMed ID: 7981639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.